• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $AROC

    Archrock Inc.

    Subscribe to $AROC
    $AROC
    Natural Gas Distribution
    Utilities

    Archrock, Inc. operates as an energy infrastructure company in the United States. It operates in two segments, Contract Operations and Aftermarket Services. The company engages in the designing, sourcing, owning, installing, operating, servicing, repairing, and maintaining its owned fleet of natural gas compression equipment to provide natural gas compression services to customers in the oil and natural gas industry. It also offers various aftermarket services, such as sale of parts and components; and provision of operation, maintenance, overhaul, and reconfiguration services to customers who own compression equipment. The company was formerly known as Exterran Holdings, Inc. and changed its name to Archrock, Inc. in November 2015. Archrock, Inc. was founded in 1990 and is headquartered in Houston, Texas.

    IPO Year:

    Exchange: NYSE

    Website: archrock.com

    Peers

    $CCLP
    $EXTN
    $NGS
    $USAC

    Recent Analyst Ratings for Archrock Inc.

    DatePrice TargetRatingAnalyst
    10/2/2024$24.00Outperform
    Mizuho
    9/27/2024$24.00Buy
    Citigroup
    9/25/2024$24.00Outperform
    Evercore ISI
    9/6/2024$24.00Overweight
    JP Morgan
    12/9/2022$10.00Outperform
    Raymond James
    See more ratings